This document discusses gastrointestinal bleeding, its causes, presentations, evaluation, and management. The most common causes of upper GI bleeding are varices, erosive gastritis, and peptic ulcers while the most common causes of lower GI bleeding are hemorrhoids, dysentery, polyps, and inflammatory bowel diseases. Evaluation involves history, physical exam, endoscopy, and other imaging modalities. Management depends on the severity and includes IV fluids, blood transfusions, endoscopic therapies, and angiography.
This document provides an overview of approaches to gastrointestinal bleeding. It discusses the common clinical presentations including hematemesis, melena, hematochezia, and occult bleeding. For hematemesis, the most common causes are discussed such as stress ulcers, Mallory-Weiss tears, peptic ulcer disease, gastroesophageal varices, and Dieulafoy's lesion. For hematochezia, common causes include colonic diverticula, internal hemorrhoids, colon cancer, and inflammatory bowel disease. The document provides details on evaluating each potential cause and characteristics to consider in the clinical history and examination.
The document discusses the approach to GI hemorrhage. It begins with the clinical presentation of GI bleeding, including symptoms of upper and lower GI bleeding. It then discusses resuscitation of patients based on bleeding severity. The causes, symptoms, and approaches to treatment of upper and lower GI bleeding are described. Diagnostic tests including endoscopy are explained. Specific causes of upper GI bleeding like peptic ulcers and varices are elaborated. Causes of lower GI bleeding including diverticular disease, angiodysplasia, and ischemia are also summarized.
This document discusses gastrointestinal bleeding (GIB). It is classified as upper GIB, arising above the ligament of Treitz, or lower GIB, arising below. Common causes of upper GIB include peptic ulcer disease, portal hypertension, Mallory-Weiss tears, and vascular anomalies. Initial management involves fluid resuscitation and endoscopy for diagnosis and treatment. Lower GIB causes include diverticulosis, angiodyplasia, and inflammatory bowel disease. The document provides details on evaluation, diagnosis, and management of GIB.
The document discusses lower gastrointestinal bleeding, including its definition, causes such as diverticular disease, inflammatory bowel disease, angiodysplasia, and coagulopathy. It covers the clinical presentation, various diagnostic tests including colonoscopy, capsule endoscopy and nuclear scintigraphy. Colonoscopy is the mainstay for evaluation as it can both diagnose the bleeding source and provide therapeutic treatment in many cases.
This document discusses gastrointestinal (GI) bleeding, including:
1) GI bleeding can present as overt (visible bleeding) or occult (hidden bleeding) and can originate from the upper or lower GI tract. Common symptoms include hematemesis, melena, and hematochezia.
2) Etiologies of upper GI bleeding include esophageal varices, peptic ulcers, Mallory-Weiss tears, and Dieulafoy's lesions. Management involves endoscopy, vasoactive drugs, proton pump inhibitors, and blood transfusions.
3) Lower GI bleeding can originate from the small intestine or colon. Causes include vascular ectasias, cancers, diverticulosis, and inflammatory bowel disease
This document discusses gastrointestinal bleeding (GIB). It is classified as upper GIB, which arises above the ligament of Treitz, or lower GIB, which arises below. Common causes of upper GIB are peptic ulcer disease, portal hypertension, Mallory-Weiss tears, vascular anomalies, gastritis, erosive esophagitis, and gastric cancer. Initial management involves fluid resuscitation, blood products, and endoscopy for diagnosis and treatment. Colonoscopy is often used to evaluate lower GIB.
1) The document provides information on the evaluation and management of bleeding per rectum (BPR). It discusses the history, physical exam, differential diagnoses, investigations and treatment options for common causes of BPR.
2) Common causes of BPR include hemorrhoids, anal fissures, colorectal polyps, inflammatory bowel disease, diverticular disease, and colorectal cancers. The history can help determine if the bleeding is from distal or proximal lesions.
3) Physical exam involves digital rectal exam to feel for masses or other abnormalities. Initial investigations include labs, endoscopy, and imaging. Treatment depends on the underlying cause but may include medications, procedures like banding or surgery.
This document outlines the principles and management of upper gastrointestinal tract bleeding. It begins with introducing common causes such as peptic ulcers, esophagitis, and variceal bleeding. It then discusses the initial assessment and resuscitation of patients, including classifying hemorrhagic shock. Risk stratification scores are described to predict the need for interventions. Specific therapies for causes like peptic ulcers, stress gastritis, and variceal bleeding are covered. Endoscopy is highlighted as the primary diagnostic and therapeutic tool. The conclusion emphasizes the multidisciplinary nature and importance of determining the bleeding source for directing treatment.
This document discusses lower gastrointestinal bleeding (LGIB), which occurs in the small and large intestines, presenting as hematochezia or melaena. Common causes of LGIB include diverticular disease, inflammatory bowel diseases like Crohn's disease and ulcerative colitis, ischemic colitis, vascular malformations, polyps, tumors, and anal issues. LGIB is typically chronic and self-limiting, though some cases are acute and require blood transfusion. The diagnostic workup depends on the patient's age and symptoms, and may involve endoscopy, imaging, or angiography to identify the source of bleeding.
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
This document discusses lower gastrointestinal (GI) bleeding, including:
- Causes such as angiodysplasia, carcinoma, diverticulosis, and anorectal diseases.
- Clinical evaluation involving history of presenting symptoms, physical exam, investigations to localize the source of bleeding such as colonoscopy, and management including resuscitation, treating the underlying cause, and potential surgical intervention for massive or recurrent bleeding.
- Diagnostic tools like colonoscopy, mesenteric angiography, and radionuclide scanning along with their advantages and disadvantages.
Imaging and intervention in hemetemesisSindhu Gowdar
油
This document discusses various imaging modalities for evaluating gastrointestinal bleeding, including hematemesis. It provides details on angiography, computed tomography angiography, and endoscopy. The key points are:
- Endoscopy is the primary initial investigation but additional techniques like CT angiography and catheter angiography may be needed when endoscopy is negative or fails to identify the bleeding source.
- CT angiography has advantages over catheter angiography as it is more widely available, non-invasive, and allows detection of bleeding sources throughout the GI tract.
- Both endoscopy and CT angiography play important roles in evaluating GI bleeding, with endoscopy also allowing for therapeutic interventions when a source is identified.
This document provides an overview of the approach to upper GI bleeding. It begins with definitions of terms like hematemesis, melena, and hematochezia. It then discusses the causes of upper GI bleeding, which can be variceal or non-variceal. For patients presenting with upper GI bleeding, the summary provides that history, physical exam, and investigations like endoscopy are important to determine the cause and guide management. Management may involve treating any active bleeding, administering PPIs for non-variceal causes, or using vasoactive agents, balloon tamponade, or endoscopic therapies for variceal bleeding.
This document provides an overview of the approach to upper GI bleeding. It begins with definitions of terms like hematemesis, melena, and hematochezia. It then discusses the causes of upper GI bleeding, which can be variceal or non-variceal. For patients presenting with upper GI bleeding, the summary provides that history, physical exam, and investigations like endoscopy are important to determine the cause and guide management. Management may involve treating any active bleeding, administering PPIs for non-variceal bleeding, or using vasoactive agents, balloon tamponade, or endoscopic therapies for variceal bleeding.
Lower gastrointestinal bleeding (LGIB) refers to blood loss originating from a site distal to the ligament of Treitz. Common causes of LGIB include hemorrhoids, diverticulosis, angiodysplasia, and anal cancers. Hematochezia is the typical presentation of LGIB. Initial workup includes examination, blood tests to check for anemia and coagulopathy, and colonoscopy for diagnosis and potential therapeutic intervention to stop bleeding. Management depends on the cause but may include conservative measures, nonsurgical options like banding or surgical procedures like hemorrhoidectomy.
A 72-year-old woman presented to the emergency room with coffee ground emesis and melena. Laboratory tests showed a hemoglobin of 8.1. Physical exam found melenic stool. The patient has a history of hypertension, diabetes, coronary artery disease, and recent myocardial infarction. This suggests a diagnosis of acute gastrointestinal bleeding, which will require endoscopy, medication treatment including PPIs and antibiotics, and possible blood transfusion or surgery.
This document discusses gastrointestinal bleeding, including:
- Gastrointestinal bleeding can arise from any location in the GI tract and represents the initial symptom of GI disease in 1/3 of patients.
- Clinical presentations of GI bleeding include hematemesis, melena, hematochezia, occult bleeding, and symptoms of blood loss/anemia.
- Common causes of upper GI bleeding are peptic ulcers and esophageal varices, while diverticulosis and colon polyps are common causes of lower GI bleeding.
- The approach to a patient with GI bleeding involves stabilizing their hemodynamic status, identifying the source of bleeding, stopping active bleeding, treating the underlying cause, and preventing recurrent
This document summarizes upper gastrointestinal bleeding (UGIB), including its causes, presentation, evaluation, management, and prognosis. It discusses specific causes like variceal bleeding, peptic ulcer bleeding, Mallory-Weiss syndrome, and Dieulafoy's lesion. For variceal bleeding, it describes treatments like band ligation, TIPS, and beta-blockers for prophylaxis. For peptic ulcers, it notes the role of PPIs, H. pylori treatment, and endoscopic therapies. The document provides an overview of evaluating and treating major causes of UGIB.
Lower GI bleeding can result from various causes in the colon and rectum. The most common etiologies are diverticular disease, which accounts for 60% of cases, and inflammatory bowel disease, which causes 13% of cases. Diverticulosis is characterized by outpouchings in the colon wall that are prone to bleeding. It is usually asymptomatic but can lead to complications like diverticulitis, abscesses, fistulas, and obstruction. Inflammatory bowel disease includes both Crohn's disease and ulcerative colitis, which cause transmural and mucosal inflammation respectively. Common symptoms of lower GI bleeding include hematochezia and melena. Treatment depends on the underlying cause but may involve medications, surgery
This document provides an overview of upper gastrointestinal bleeding, including:
- The definition, incidence, mortality, and common causes of upper GI bleeding. The most common causes are gastric and duodenal ulcers, esophagitis, and esophageal varices.
- Principles of management including initial assessment, resuscitation, localization of bleeding site usually through endoscopy, and risk stratification to determine need for inpatient care or intervention.
- Endoscopy is the gold standard for diagnosis and treatment. The Forrest classification guides prognosis and need for endoscopic therapy based on stigmata of recent hemorrhage seen. Proton pump inhibitors are commonly used for prevention of rebleeding.
- Viral hepatitis can present asymptomatically, symptomatically before jaundice, or progress to fulminant hepatitis or chronic hepatitis. Diagnosis involves blood tests to check liver enzymes and serology or molecular testing to determine the virus.
- Liver abscesses can be pyogenic (most common), amebic, or fungal. Amebic abscesses are caused by Entamoeba histolytica and present with fever, abdominal pain, and hepatomegaly. Pyogenic abscesses require drainage if large or not improving with antibiotics.
- Hydatid cysts are caused by the tapeworm Echinococcus granulosus. Surgical removal is usually required for large or infected cysts while
1) The document provides information on the evaluation and management of bleeding per rectum (BPR). It discusses the history, physical exam, differential diagnoses, investigations and treatment options for common causes of BPR.
2) Common causes of BPR include hemorrhoids, anal fissures, colorectal polyps, inflammatory bowel disease, diverticular disease, and colorectal cancers. The history can help determine if the bleeding is from distal or proximal lesions.
3) Physical exam involves digital rectal exam to feel for masses or other abnormalities. Initial investigations include labs, endoscopy, and imaging. Treatment depends on the underlying cause but may include medications, procedures like banding or surgery.
This document outlines the principles and management of upper gastrointestinal tract bleeding. It begins with introducing common causes such as peptic ulcers, esophagitis, and variceal bleeding. It then discusses the initial assessment and resuscitation of patients, including classifying hemorrhagic shock. Risk stratification scores are described to predict the need for interventions. Specific therapies for causes like peptic ulcers, stress gastritis, and variceal bleeding are covered. Endoscopy is highlighted as the primary diagnostic and therapeutic tool. The conclusion emphasizes the multidisciplinary nature and importance of determining the bleeding source for directing treatment.
This document discusses lower gastrointestinal bleeding (LGIB), which occurs in the small and large intestines, presenting as hematochezia or melaena. Common causes of LGIB include diverticular disease, inflammatory bowel diseases like Crohn's disease and ulcerative colitis, ischemic colitis, vascular malformations, polyps, tumors, and anal issues. LGIB is typically chronic and self-limiting, though some cases are acute and require blood transfusion. The diagnostic workup depends on the patient's age and symptoms, and may involve endoscopy, imaging, or angiography to identify the source of bleeding.
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
Approach to patient with upper GIT bleeding
This document discusses lower gastrointestinal (GI) bleeding, including:
- Causes such as angiodysplasia, carcinoma, diverticulosis, and anorectal diseases.
- Clinical evaluation involving history of presenting symptoms, physical exam, investigations to localize the source of bleeding such as colonoscopy, and management including resuscitation, treating the underlying cause, and potential surgical intervention for massive or recurrent bleeding.
- Diagnostic tools like colonoscopy, mesenteric angiography, and radionuclide scanning along with their advantages and disadvantages.
Imaging and intervention in hemetemesisSindhu Gowdar
油
This document discusses various imaging modalities for evaluating gastrointestinal bleeding, including hematemesis. It provides details on angiography, computed tomography angiography, and endoscopy. The key points are:
- Endoscopy is the primary initial investigation but additional techniques like CT angiography and catheter angiography may be needed when endoscopy is negative or fails to identify the bleeding source.
- CT angiography has advantages over catheter angiography as it is more widely available, non-invasive, and allows detection of bleeding sources throughout the GI tract.
- Both endoscopy and CT angiography play important roles in evaluating GI bleeding, with endoscopy also allowing for therapeutic interventions when a source is identified.
This document provides an overview of the approach to upper GI bleeding. It begins with definitions of terms like hematemesis, melena, and hematochezia. It then discusses the causes of upper GI bleeding, which can be variceal or non-variceal. For patients presenting with upper GI bleeding, the summary provides that history, physical exam, and investigations like endoscopy are important to determine the cause and guide management. Management may involve treating any active bleeding, administering PPIs for non-variceal causes, or using vasoactive agents, balloon tamponade, or endoscopic therapies for variceal bleeding.
This document provides an overview of the approach to upper GI bleeding. It begins with definitions of terms like hematemesis, melena, and hematochezia. It then discusses the causes of upper GI bleeding, which can be variceal or non-variceal. For patients presenting with upper GI bleeding, the summary provides that history, physical exam, and investigations like endoscopy are important to determine the cause and guide management. Management may involve treating any active bleeding, administering PPIs for non-variceal bleeding, or using vasoactive agents, balloon tamponade, or endoscopic therapies for variceal bleeding.
Lower gastrointestinal bleeding (LGIB) refers to blood loss originating from a site distal to the ligament of Treitz. Common causes of LGIB include hemorrhoids, diverticulosis, angiodysplasia, and anal cancers. Hematochezia is the typical presentation of LGIB. Initial workup includes examination, blood tests to check for anemia and coagulopathy, and colonoscopy for diagnosis and potential therapeutic intervention to stop bleeding. Management depends on the cause but may include conservative measures, nonsurgical options like banding or surgical procedures like hemorrhoidectomy.
A 72-year-old woman presented to the emergency room with coffee ground emesis and melena. Laboratory tests showed a hemoglobin of 8.1. Physical exam found melenic stool. The patient has a history of hypertension, diabetes, coronary artery disease, and recent myocardial infarction. This suggests a diagnosis of acute gastrointestinal bleeding, which will require endoscopy, medication treatment including PPIs and antibiotics, and possible blood transfusion or surgery.
This document discusses gastrointestinal bleeding, including:
- Gastrointestinal bleeding can arise from any location in the GI tract and represents the initial symptom of GI disease in 1/3 of patients.
- Clinical presentations of GI bleeding include hematemesis, melena, hematochezia, occult bleeding, and symptoms of blood loss/anemia.
- Common causes of upper GI bleeding are peptic ulcers and esophageal varices, while diverticulosis and colon polyps are common causes of lower GI bleeding.
- The approach to a patient with GI bleeding involves stabilizing their hemodynamic status, identifying the source of bleeding, stopping active bleeding, treating the underlying cause, and preventing recurrent
This document summarizes upper gastrointestinal bleeding (UGIB), including its causes, presentation, evaluation, management, and prognosis. It discusses specific causes like variceal bleeding, peptic ulcer bleeding, Mallory-Weiss syndrome, and Dieulafoy's lesion. For variceal bleeding, it describes treatments like band ligation, TIPS, and beta-blockers for prophylaxis. For peptic ulcers, it notes the role of PPIs, H. pylori treatment, and endoscopic therapies. The document provides an overview of evaluating and treating major causes of UGIB.
Lower GI bleeding can result from various causes in the colon and rectum. The most common etiologies are diverticular disease, which accounts for 60% of cases, and inflammatory bowel disease, which causes 13% of cases. Diverticulosis is characterized by outpouchings in the colon wall that are prone to bleeding. It is usually asymptomatic but can lead to complications like diverticulitis, abscesses, fistulas, and obstruction. Inflammatory bowel disease includes both Crohn's disease and ulcerative colitis, which cause transmural and mucosal inflammation respectively. Common symptoms of lower GI bleeding include hematochezia and melena. Treatment depends on the underlying cause but may involve medications, surgery
This document provides an overview of upper gastrointestinal bleeding, including:
- The definition, incidence, mortality, and common causes of upper GI bleeding. The most common causes are gastric and duodenal ulcers, esophagitis, and esophageal varices.
- Principles of management including initial assessment, resuscitation, localization of bleeding site usually through endoscopy, and risk stratification to determine need for inpatient care or intervention.
- Endoscopy is the gold standard for diagnosis and treatment. The Forrest classification guides prognosis and need for endoscopic therapy based on stigmata of recent hemorrhage seen. Proton pump inhibitors are commonly used for prevention of rebleeding.
- Viral hepatitis can present asymptomatically, symptomatically before jaundice, or progress to fulminant hepatitis or chronic hepatitis. Diagnosis involves blood tests to check liver enzymes and serology or molecular testing to determine the virus.
- Liver abscesses can be pyogenic (most common), amebic, or fungal. Amebic abscesses are caused by Entamoeba histolytica and present with fever, abdominal pain, and hepatomegaly. Pyogenic abscesses require drainage if large or not improving with antibiotics.
- Hydatid cysts are caused by the tapeworm Echinococcus granulosus. Surgical removal is usually required for large or infected cysts while
Thyroid cancer overview in global and African settings including MalawiTimWiyuleMutafyaMD
油
thyroid cancer local and global review with approach to diagnosis and treatment. Summary and pictures which aid a resident both in low and high resource areas. interesting trends in all regions
Small intestine Nutrition pdf. Dr Tim Wiyule Mutafya. General surgery at kamu...TimWiyuleMutafyaMD
油
The document discusses the anatomy, physiology, and function of the small intestine. It provides details on the three parts of the small intestine (duodenum, jejunum, and ileum), describing their lengths, diameters, and surface areas. It explains the role of plicae circulares, villi, and microvilli in enhancing nutrient absorption. The roles of various intestinal cells and the mechanical and chemical processes involved in digestion of carbohydrates, lipids, and proteins are summarized. Short bowel syndrome resulting from resection of over half of the small intestine is also discussed.
This document discusses the histology and microscopic anatomy of the pancreas. It describes the exocrine and endocrine components. The exocrine pancreas is composed of acinar cells that secrete digestive enzymes into small ducts. The endocrine pancreas is made up of islets of Langerhans, which contain alpha, beta, delta, and F cells that secrete glucagon, insulin, somatostatin, and pancreatic polypeptide respectively. The document also discusses pancreatic stellate cells and their role in fibrosis and repair after pancreatic injury.
Ventriculitis is an inflammation of the ependymal lining of the cerebral ventricles that is usually secondary to infection from meningitis, devices, or trauma. It presents with non-specific symptoms like fever and headache. Diagnosis involves analysis of CSF showing elevated white blood cells and proteins with normal or low glucose. Management includes high dose intravenous antibiotics, removal of any devices, and monitoring of CSF parameters until infection clears. Outcomes are better when the infecting organism has low virulence and treatment includes both antibiotics and device removal.
This document discusses duodenal anatomy, tumors, and surgical management. It covers the following key points in 3 sentences:
Benign duodenal tumors include adenomas, lipomas, and neuroendocrine tumors. Malignant tumors are mostly adenocarcinomas. Surgical approaches depend on tumor location and include pancreaticoduodenectomy for periampullary or distal tumors, and segmental resection for proximal tumors.
Barrett's Esophagus is an acquired metaplastic condition in which healthy油squamous epithelium油is replaced by specialized油intestinal columnar epithelium.
Occurs in 10-15% of patients with GERD. Prevalence of 0.9-10%(2%) in general adult population
Poor data in Africa because of absence of screening programs
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsKHUSHAL CHAVAN
油
This presentation provides a comprehensive overview of optimization in pharmaceutical formulations. It explains the concept of optimization, different types of optimization problems (constrained and unconstrained), and the mathematical principles behind formulation development. Key topics include:
Methods for optimization (Sequential Simplex Method, Classical Mathematical Methods)
Statistical analysis in optimization (Mean, Standard Deviation, Regression, Hypothesis Testing)
Factorial Design & Quality by Design (QbD) for process improvement
Applications of optimization in drug formulation
This resource is beneficial for pharmaceutical scientists, R&D professionals, regulatory experts, and students looking to understand pharmaceutical process optimization and quality by design approaches.
Non-Invasive ICP Monitoring for NeurosurgeonsDhaval Shukla
油
This presentation delves into the latest advancements in non-invasive intracranial pressure (ICP) monitoring techniques, specifically tailored for neurosurgeons. It covers the importance of ICP monitoring in clinical practice, explores various non-invasive methods, and discusses their accuracy, reliability, and clinical applications. Attendees will gain insights into the benefits of non-invasive approaches over traditional invasive methods, including reduced risk of complications and improved patient outcomes. This comprehensive overview is designed to enhance the knowledge and skills of neurosurgeons in managing patients with neurological conditions.
Invasive systems are commonly used for monitoring intracranial pressure (ICP) in traumatic brain injury (TBI) and are considered the gold standard. The availability of invasive ICP monitoring is heterogeneous, and in low- and middle-income settings, these systems are not routinely employed due to high cost or limited accessibility. The aim of this presentation is to develop recommendations to guide monitoring and ICP-driven therapies in TBI using non-invasive ICP (nICP) systems.
Best Sampling Practices Webinar USP <797> Compliance & Environmental Monito...NuAire
油
Best Sampling Practices Webinar USP <797> Compliance & Environmental Monitoring
Are your cleanroom sampling practices USP <797> compliant? This webinar, hosted by Pharmacy Purchasing & Products (PP&P Magazine) and sponsored by NuAire, features microbiology expert Abby Roth discussing best practices for surface & air sampling, data analysis, and compliance.
Key Topics Covered:
鏝 Viable air & surface sampling best practices
鏝 USP <797> requirements & compliance strategies
鏝 How to analyze & trend viable sample data
鏝 Improving environmental monitoring in cleanrooms
・ Watch Now: https://www.nuaire.com/resources/best-sampling-practices-cleanroom-usp-797
Stay informedfollow Abby Roth on LinkedIn for more cleanroom insights!
Chair and Presenters Sara A. Hurvitz, MD, FACP, Carey K. Anders, MD, FASCO, and Vyshak Venur, MD, discuss metastatic HER2-positive breast cancer in this CME/NCPD/CPE/AAPA/IPCE activity titled Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences. For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4f8sUs7. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.
Stability of Dosage Forms as per ICH GuidelinesKHUSHAL CHAVAN
油
This presentation covers the stability testing of pharmaceutical dosage forms according to ICH guidelines (Q1A-Q1F). It explains the definition of stability, various testing protocols, storage conditions, and evaluation criteria required for regulatory submissions. Key topics include stress testing, container closure systems, stability commitment, and photostability testing. The guidelines ensure that pharmaceutical products maintain their identity, purity, strength, and efficacy throughout their shelf life. This resource is valuable for pharmaceutical professionals, researchers, and regulatory experts.
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVAN
油
This presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
At Macafem, we provide 100% natural support for women navigating menopause. For over 20 years, we've helped women manage symptoms, and in 2024, we're proud to share their heartfelt experiences.
BIOMECHANICS OF THE MOVEMENT OF THE SHOULDER COMPLEX.pptxdrnidhimnd
油
The shoulder complex acts as in coordinated fashion to provide the smoothest and greatest range of motion possible of the upper limb.
Combined motion of GH and ST joint of shoulder complex helps in:
Distribution of motion between other two joints.
Maintenance of glenoid fossa in optimal position.
Maintenance of good length tension
Although some amount of glenohumeral motion may occur while the other shoulder articulations remain stabilized, movement of the humerus more commonly involves some movement at all three shoulder joints.
ECZEMA 3rd year notes with images .pptxAyesha Fatima
油
If its not Itch Its not Eczema
Eczema is a group of medical conditions which causes inflammation and irritation to skin.
It is also called as Dermatitis
Eczema is an itchy consisting of ill defined erythremotous patches. The skin surface is usually scaly and As time progress, constant scratching leads to thickened lichenified skin.
Several classifications of eczemas are available based on Etiology, Pattern and chronicity.
According to aetiology Eczema are classified as:
Endogenous eczema: Where constitutional factors predispose the patient to developing an eczema.
Family history (maternal h/o eczema) is often present
Strong genetic predisposition (Filaggrin gene mutations are often present).
Filaggrin is responsible for maintaining moisture in skin (hence all AD patients have dry skin.
Immunilogical factor-Th-2 disease, Type I hypersensitivity (hence serum IgE high)
e.g., Seborrheic dermatitis, Statis dermatitis, Nummular dermatitis, Dyshidrotic Eczema
Exogenous eczema: Where external stimuli trigger development of eczema,
e.g., Irritant dermatitis, Allergic Dermatitis, Neurodermatitis,
Combined eczema: When a combination of constitutional factors and extrinsic triggers are responsible for the development of eczema
e.g., Atopic dermatitis
Extremes of Temperature
Irritants : Soaps, Detergents, Shower gels, Bubble baths and water
Stress
Infection either bacterial or viral,
Bacterial infections caused by Staphylococcus aureus and Streptococcus species.
Viral infections such as Herpes Simplex, Molluscum Contagiosum
Contact allergens
Inhaled allergens
Airborne allergens
Allergens include
Metals eg. Nickle, Cobalt
Neomycin, Topical ointment
Fragrance ingredients such as Balsam of Peru
Rubber compounds
Hair dyes for example p-Phenylediamine
Plants eg. Poison ivy .
Atopic Dermatitis : AD is a chronic, pruritic inflammatory skin disease characterized by itchy inflamed skin.
Allergic Dermatitis: A red itchy weepy reaction where the skin has come in contact with a substance That immune system recognizes as foreign substances.
Ex: Poison envy, Preservatives from creams and lotions.
Contact Irritant Dermatitis: A Localized reaction that include redness, itching and burning where the skin has come In contact with an allergen or with irritant such as acid, cleaning agent or chemical.
Dyshidrotic Eczema: Irritation of skin on the palms and soles by
clear deep blisters that itch and burn.
Clinical Features; Acute Eczema:- Acute eczema is characterized by an erythematous and edematous plaque, which is ill-defined and is surmounted by papules, vesicles, pustules and exudate that dries to form crusts. A subsiding eczematous plaque may be covered with scales.
Chronic Eczema:- Chronic eczema is characterized by lichenification, which is a triad of hyperpigmentation, thickening markings. The lesions are less exudative and more scaly. Flexural lesions may develop fissures.
Pruritus
Characteristic Rash
Chronic or repeatedly occurring symptoms.
The course covers the steps undertaken from tissue collection, reception, fixation,
sectioning, tissue processing and staining. It covers all the general and special
techniques in histo/cytology laboratory. This course will provide the student with the
basic knowledge of the theory and practical aspect in the diagnosis of tumour cells
and non-malignant conditions in body tissues and for cytology focusing on
gynaecological and non-gynaecological samples.
3. Definition
Upper GIB is that originating proximal to the ligament of Treitz;
from the oesophagus, stomach and duodenum
4. EPIDEMIOLOGY
UGIB is more common than bleeding from the lower GI tract, accounting for 70% of
all gastrointestinal bleeding.
80% are self-limited.
Most common source is stomach and proximal duodenum due to peptic ulcer
Pts on anti platelet therapy has two fold increase in bleed as compared to normal
ones.
20% of pts of moderate to high risk, who have recurrent bleeding (within 48-72 hrs)
have poor prognosis.
The mortality rate is 5% to 10% for severe UGI bleed.
5. RISK FACTORS
Age > 50 years, Male
Drugs: Use of NSAIDS, antiplatelet
H-pylori infection
Excessive alcohol intake
Excess acid production
10. Esophageal
Varices
Gastric
Associated with high HPVG > 12mmHg
About 40% of patients with cirrhosis and in
60% of patients with cirrhosis and ascites.
Up to 25% of patients with newly diagnosed
varices will bleed within two years.
80% will stop bleeding spontaneously.
Can occur with HVPG less than 12 mm Hg
High risk
Not usually associated with cirrhosis
o splenic vein thrombosis
o Pancreatitis
o pancreatic cancer.
13. Most frequent cause of upper GI Bleeding
Duodenal Ulcer-gastroduodenal A.
PUD
Gastric ulcer-left gastric A.
PEPTIC ULCER DISEASE
H.PYLORI: NSAIDS:
* involves antrum * gastric ulcers >
common
*duodenal ulcers * 15-45% patients
develop
ulcers on regular use
As the ulcer burrows deeper into the
gastroduodenal mucosa,weakening and
necrosis of the arterial wall,development
of a pseudoaneurysm.
weakened wall ruptures hemorrhage
15. Mallory weiss syndrome / tears
Mucosal or sub-mucosal lacerations that occur at the
gastro-esophageal junction and usually extend distally
into a hiatal hernia .
Typically have a history of recent non-bloody vomiting
with excessive retching followed by hematemesis..
Endoscopy usually reveals a single tear that begins at
the gastro-esophageal junction and extends several
millimeters distally into a hiatal hernia sac/within
cardiac portion of stomach.
16. Haemorragic/Erosive gastritis
Stress related mucosal injury
Occur mostly in extremly sick patients
Major Trauma
Post Major Surgery
3rd Degree burns
Major intracranial disease
Severe medical illness (Ventilator dependence, coagulopathy)
Significant bleeding probably does not develop unless ulceration occurs.
Intravenous H2-receptor antagonist is the treatment of choice. Sucralfate
also effective
Aspirin and NSAIDS
Half of the patient who chronically ingest NSAIDS have Erosions. (15 30%
have Ulcers)
Most Frequently and severely affected site is gastric antrum.
17. PORTAL GASTROPATHY
On endoscopic examination mucosa is engorged and
friable.
Portal hypertensive gastropathy (PHG) is caused by
increased portal venous pressure and severe mucosal
hyperemia that results in ectatic blood vessels in the
proximal gastric body and cardia and oozing of
blood.
Less severe grades of PHG appear as a mosaic or
snake skin appearance and are not associated with
bleeding.
Usually, patients with severe PHG present with chronic
blood loss, but they occasionally can present with
acute bleeding.
18. DIEULAFOY'S LESION
It is a large (1- to 3-mm) submucosal artery that protrudes
through the mucosa.
It is not associated with a peptic ulcer, and can cause
massive bleeding.
It usually is located in the gastric fundus, within 6 cm of the
gastroesophageal junction.
Dieulafoy's lesion can be difficult to identify at endoscopy
because of the intermittent nature of the bleeding.
the overlying mucosa may appear normal if the lesion is not
bleeding.
19. GASTRIC ANTRAL VASCULAR ECTASIA
Gastric antral vascular ectasia (GAVE), also described as watermelon
stomach.
Characterized by rows or stripes of ectatic mucosal blood vessels that
emanate from the pylorus and extend proximally into the antrum .
Unknown etiology
Common in older
women and patients
with ESRD
20. Aortoenteric fistula
The A-E fistula is a communication between the
native abdominal aorta and, most commonly,
the third portion of the duodenum.
Bleeding is usually acute and massive, with a high
mortality rate(30-100%).
Often, a self-limited herald bleed occurs hours to
months before a more severe, exsanguinating
bleed.
The fistula usually forms between three and five
years after graft placement.
22. 1. Hematemesis
Vomiting of red blood or coffee- grounds
material when gastric acid converts hemoglobin
into methemoglobin .
Differentiate from :-
Hemoptysis.
Bleeding from Pharynx , nasal passage
USUALLY hematemesis requires a bucket; BUT haemoptysis
a small bowl.
23. 2. Melena
Passage of black tarry stools.
EBL > 50-100 ml /day will produce melena.
The black color is caused by Hematin, the
product of oxidation of Heme by intestinal
and bacterial enzymes.
10% LGI bleed
Can be swallowed blood from epistaxis
Blood for 14 hrs in the GI tract
Drugs like Oral iron and bismuth mimics
melena.
3. Hematochezia
It is defined as passage of bright-red or
maroon blood from the rectum.
Common in bleeding from colon, rectum
and anus.
In case of brisk bleeding in the UGI, bright
red blood may come out unchanged in
the stool.
10% of UGI bleed
Symptoms of blood loss or anemia
Light headedness, syncope, angina, or dyspnea, palpitations
24. Aetiology Leading history
MalloryWeiss tear Multiple Emesis before hematemesis, alcoholism, retching
Esophageal ulcer Dysphagia, Odynophagia, GERD
Peptic ulcer Epigastric pain, NSAID or aspirin use
Stress gastritis Patient in an ICU, gastrointestinal bleeding occurring
after admission,respiratory failure,multiorgan failure,coagulopathy
Varices, portal
gastropathy
Alcoholism, Cirrhosis of liver
Gastric antral
vascular ectasia
Renal failure, cirrhosis
Malignancy Recent involuntary weight loss, dysphagia, cachexia,
early satiety
Angiodysplasia Chronic renal failure, hereditary hemorrhagic
telangiectasia
Aortoenteric fistula Known aortic aneurysm, prior abdominal aortic
aneurysm repair
Clues regarding the cause of acute UGI bleeding
28. Leuconychia Gynecomastia
Bleeding manifestations Scars of previous surgery
29. Splenomegaly
Caput medusae
Parotid Swelling
Fetor hepaticus
Asterixis
Testicular atrophy
Acanthosis nigricans
Alopecia
Glossitis
Loss of Axillary hair
Loss of Pubic Hair
31. APPROACH TO A PATIENT WITH
UGIB
Immediate Initial Assessment
Stabilization of haemodynamic status
Identify bleed source
Stop active bleed
Treat underlying cause
Prevent recurrence of bleeding
32. Risk assessment & triage
Risk for mortality and
rebleeding.
Categorised as
low,
intermediate
high risk
Record the GCS
Poo prognostic factors
1. Age over 60
2. Shock(SBP<100mmhg), pulse >100
3. Malignancy or varices as bleeding source.
4. Severe coagulopathy
5. Comorbid medical illness
6. Continued or recurrent bleeding
7. Multi-organ failure
33. Workup
Bloods
Hematology - FBC, G+ crossmatch
Biochemistry- U&Es, LFT+ albumin
Serology - H-pylori, Hep B/C,HIV, schistosomiasis
Coagulation profile
Stool: occult blood
Imaging
Esophagogastroduodenoscopy
o Therapeutic and diagnostic
CXR
ECG
Abdominal USS
CT Angiography
34. MANAGEMENT OF UGIB
GENERAL MEDICAL
MANAGEMENT
TYPE OF BLEEDING
VARICEAL
BLEEDING
NON VARICEAL
BLEEDING
MEDICAL ENDOTHERAPY
SURGICAL
INERVENTION
PRESSURE
TECHNIQUES
35. AUGIB
Rapid Assessment
Monitor Hemodynamic Status
Fluid Resuscitation
Ryle;s tube for Gastric Lavage
Self Limited Hemorrhage (80%) Continued bleeding (10-25%)
Urgent endoscopy
Recurrent Hemorrhage
Elective Endoscopy
(With in 24 48 hours)
Definitive Therapy
(If Necessary)
Site not localized Localized
Further Assessment
(Extended EGD,
Radio-isotope
scan,
Arteriography,
Exploratory Definitive